Medical News

RSS

'Secondary over-triage' identified as potential area of cost savings for health care

Researchers at the University of California, San Diego School of Medicine have identified "secondary over-triage" as a potential area of cost savings for our nation's health care. The phenomenon of over-triage occurs when patients are transferred twice, and discharged from a second facility in less than 24 hours. These findings will be published in the September 10th issue of The Journal of Trauma.

10 Sep 2010

Research can helps to develop targeted psychological intervention to assist couples cope with PVD

An investigation published in The Journal of Sexual Medicine has found that male partners who express greater support, attention and sympathy to women's chronic vulvovaginal pain may trigger more pain, but also increase sexual satisfaction in female partners.

10 Sep 2010

John Theurer Cancer Center plays major role in FDA's fast tracking of ipilimumab for metastatic melanoma

Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an important role in a study that led to the Food & Drug Administration's (FDA) recent fast tracking of ipilimumab, a promising treatment for metastatic melanoma. The FDA based its decision largely on the results of a pivotal study published in the New England Journal of Medicine on August 19, 2010 – the same day the agency accepted Bristol-Myers Squibb's application for the drug's approval and granted the application priority review status.

10 Sep 2010

Sec. of State Clinton discusses Obama administration's foreign policy strategy

In a speech on Wednesday at the Council on Foreign Relations, Secretary of State Hillary Rodham Clinton outlined the Obama administration's approach to foreign policy and said that U.S. "global leadership is essential, even if we must often lead in new ways," the Washington Post reports.

10 Sep 2010

NICE releases new guidelines to improve cancer care

The National Institute for Health and Clinical Excellence (NICE) has published a new guideline which should help to improve care for thousands of patients with advanced cancer that has spread from an unknown primary location.

10 Sep 2010

Diplomat Specialty Pharmacy ranked #554 on Inc.'s Top 5000 list of fastest-growing private companies

Diplomat Specialty Pharmacy announced today they have earned a position of 554 on Inc. Magazine's exclusive, annual ranking of the fastest-growing private companies in America.

10 Sep 2010

Koronis Pharmaceuticals to present KP-1461 clinical trial data at ICAAC Conference

Koronis Pharmaceuticals, Inc., a biotechnology company focused on the development of antiviral therapeutics, today announced that clinical trial data demonstrating that the Company's lead HIV drug, KP-1461, resulted in increased HIV mutations consistent with the Viral Decay Acceleration mechanism will be featured in a late-breaker oral presentation by James Mullins, Ph.D., Professor of Microbiology and Medicine at the University of Washington, at the upcoming 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) taking place in Boston, MA.

10 Sep 2010

GE Healthcare to showcase molecular imaging portfolio at WMIC

Reinforcing its commitment to researchers and clinicians, GE Healthcare, a unit of General Electric Company is showcasing a comprehensive molecular imaging portfolio—encompassing tracer development, pre-clinical imaging and highly advanced imaging equipment— to provide insight into the origins of disease, at the World Molecular Imaging Congress (WMIC), Booth #212, September 8 through 11 in Kyoto, Japan.

10 Sep 2010

Dow Jones Sustainability World Index renews inclusion of Bayer

Bayer stock has been included once again in the Dow Jones Sustainability World Index (DJSI World), providing renewed proof of the standing of the company as an international leader in sustainability. Bayer is thus one of very few companies headquartered in Germany to have been listed in the DJSI World without interruption since the establishment of the index in 1999.

10 Sep 2010

Illinois researcher urges CDC to revisit pediatric vaccine stockpile policies

Vaccine manufacturers and public health decision-makers need to collaborate in a more efficient and effective manner not only to reduce the likelihood of supply shortages for pediatric vaccines but also to maximize community immunity by using vaccine doses to increase coverage, according to research published by a University of Illinois researcher who specializes in statistics and data analysis.

10 Sep 2010

Government economists say health overhaul won't significantly increase spending

Kaiser Health News staff writer Christopher Weaver reports: "The health overhaul legislation and other changes made by Congress and regulators since February will have only a 'moderate' effect on the nation's health tab through 2019, government economists say in a new study" (Weaver, 9/9).

10 Sep 2010

FDA issues warning letters to five electronic cigarette distributors

The U.S. Food and Drug Administration today issued warning letters to five distributors for various violations of the Federal Food, Drug, and Cosmetic Act (FDCA) including unsubstantiated claims and poor manufacturing practices.

10 Sep 2010

Change in sociodemographic factors increases substance abuse treatment admissions: SAMHSA

Admissions for substance abuse treatment among those aged 50 and older have more than doubled, and their sociodemographic characteristics have significantly changed, between 1992 and 2008, according to a study by the Substance Abuse and Mental Health Services Administration (SAMHSA).The findings indicate that sociodemographic factors such as unemployment, lack of income and homelessness all increased among this treatment group during this period.

10 Sep 2010

KHN column: Don't discount the value of an agent, they discount your insurance

In this column for Kaiser Health News, Janet Trautwein, CEO of the National Association of Health Underwriters, notes: "Insurance agents have made for popular punching bags in recent weeks.

10 Sep 2010

GBCAs carry new warnings on their labels about risk of NSF: FDA

The U.S. Food and Drug Administration is requiring that gadolinium-based contrast agents (GBCAs) carry new warnings on their labels about the risk of a rare and potentially fatal condition known as nephrogenic systemic fibrosis, if the drug is administered to certain patients with kidney disease.

10 Sep 2010

Meditrina licensor AstraZeneca granted US allowance of patent for endometriosis treatment

Meditrina Pharmaceuticals, Inc., a clinical-stage, specialty pharmaceutical company focused on developing and commercializing innovative therapies that treat women's reproductive system disorders, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance of a patent entitled "Composition Comprising a Combination of an Aromatase Inhibitor, a Progestin, and an Oestrogen and its Use for the Treatment of Endometriosis" to the Company's licensor AstraZeneca.

10 Sep 2010

SAEC collaborates with Newcastle University for drug induced liver injury research

The International Serious Adverse Events Consortium (SAEC) announced today it will collaborate with Newcastle University to research the genetics of drug induced liver injury.

10 Sep 2010

Overhaul's effect on health spending minimal, government study says

The health overhaul and other recent legislative and regulatory changes will only modestly increase the nation's health tab through 2019, according to a government study published today, Kaiser Health News reports.

10 Sep 2010

Assessing the needs of disabled Medicare beneficiaries

Kaiser Health News staff writer Jessica Marcy reports in this KHN short take: "Policy makers need more concrete information about the characteristics of the disabled community and its unique challenges, a senior White House adviser said today at a forum about Medicare disability and health care reform" (Marcy, 9/9).

10 Sep 2010

Translational Research issue focuses field of stem cell research, therapy

The use of stem cells for research and their possible application in the treatment of disease are hotly debated topics. In a special issue of Translational Research published this month an international group of medical experts presents an in-depth and balanced view of the rapidly evolving field of stem cell research and considers the potential of harnessing stem cells for therapy of human diseases including cardiovascular diseases, renal failure, neurologic disorders, gastrointestinal diseases, pulmonary diseases, neoplastic diseases, and type 1 diabetes mellitus.

10 Sep 2010

Medical News

'Secondary over-triage' identified as potential area of cost savings for health care

Research can helps to develop targeted psychological intervention to assist couples cope with PVD

John Theurer Cancer Center plays major role in FDA's fast tracking of ipilimumab for metastatic melanoma

Sec. of State Clinton discusses Obama administration's foreign policy strategy

NICE releases new guidelines to improve cancer care

Diplomat Specialty Pharmacy ranked #554 on Inc.'s Top 5000 list of fastest-growing private companies

Koronis Pharmaceuticals to present KP-1461 clinical trial data at ICAAC Conference

GE Healthcare to showcase molecular imaging portfolio at WMIC

Dow Jones Sustainability World Index renews inclusion of Bayer

Illinois researcher urges CDC to revisit pediatric vaccine stockpile policies

Government economists say health overhaul won't significantly increase spending

FDA issues warning letters to five electronic cigarette distributors

Change in sociodemographic factors increases substance abuse treatment admissions: SAMHSA

KHN column: Don't discount the value of an agent, they discount your insurance

GBCAs carry new warnings on their labels about risk of NSF: FDA

Meditrina licensor AstraZeneca granted US allowance of patent for endometriosis treatment

SAEC collaborates with Newcastle University for drug induced liver injury research

Overhaul's effect on health spending minimal, government study says

Assessing the needs of disabled Medicare beneficiaries

Translational Research issue focuses field of stem cell research, therapy

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News